Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Sciobio Biotechnology is a platform-based biotechnology company focused on the development of original technologies in regenerative medicine and nanomedicine. Founded by a team of scientists, the company leverages its proprietary 3D-CC technology and 3D-STSAO intelligent manufacturing systems to innovate in fields such as synthetic biology, drug development, and protein engineering. Sciobio's strategic vision involves the creation of disruptive products for clinical and aesthetic applications, with a particular emphasis on overcoming challenges in drug delivery across the blood-brain barrier. The company operates as a private entity and is deeply integrated into the high-tech innovation ecosystem of Chengdu, China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Science.